Abstract:Background: In vitro maturation (IVM) is indicated in women with polycystic ovary syndrome (PCOS) who have a very good ovarian response during in vitro fertilization (IVF) and are therefore at high risk of ovarian hyperstimulation syndrome (OHSS). According to the latest practice committee document, IVM could be a major advance in assisted reproductive technology (ART) procedures (reduced cost and simplified treatment); nevertheless, retrospective studies of IVM versus IVF still demonstrate lower chances of a live birth with IVM. Could IVM prove to be an optimal first-line treatment approach? And limited information is available concerning the success of the subsequent IVF cycle after the failure of an IVM cycle. Does IVM treatment adversely affect the subsequent IVF cycle, and is this worth considering before performing the IVF cycle for women with PCOS? Methods: This prospective nested case-control study at the Peking University Reproductive Medicine center in China was performed between March 2018 and September 2020. Women aged 20-38 years with PCOS and infertility and who were scheduled for their first IVF attempt were eligible. A total of 351 women were randomly allocated to receive one cycle of unstimulated natural IVM (n = 175) or one cycle of standard IVF with a flexible GnRH antagonist protocol followed by hCG as an ovulation trigger (n = 176). This study involved 234 women (58 women with no blastocysts in the first IVM cycle and 158 women who underwent the first IVF cycle). Cumulative live birth rate at 12 months after oocyte retrieval and OHSS of a standard controlled ovarian stimulation (COS) IVF cycle were compared between 58 women in an IVF cycle following a failed IVM cycle and 158 women who underwent the first IVF cycle. Results: No significant differences were found in the cumulative live birth rate (CLBR), ongoing pregnancy rate, or clinical pregnancy rate at 12 months after oocyte retrieval between the two groups (56.9% vs. 58.9%, p = 0.795; 58.6% vs. 60.8%, p = 0.776; and 84.5% vs. 76.0%, p = 0.178). The incidence of moderate-to-severe OHSS was not significantly different between the groups (6.9% vs. 5.7%, p = 0.742). Additionally, there were no significant differences in the total gonadotropin dose, stimulation duration, number of retrieved oocytes, number of retrieved mature oocytes, or fertilization rates. Conclusions: Even if the first IVM attempt failed in subfertile women with PCOS, comparable cumulative live birth rates were observed in the subsequent IVF cycle. IVM treatment does not adversely affect the subsequent IVF cycle.

Pregnancy Outcomes in Women with Polycystic Ovary Syndrome after in vitro Oocyte Maturation

A Comparison of the Miscarriage Rate Between Women with and Without Polycystic Ovarian Syndrome Undergoing IVF Treatment

In Vitro Maturation and Fertilization of Oocytes from Unstimulated Cycles in Women with Infertility Due to Polycystic Ovary Syndrome

Comparison of in vitro maturation and in vitro fertilization for polycystic ovary syndrome patients: a systematic review and meta-analysis

Pregnancy Outcomes of Patients with Polycystic Ovary Syndrome after in Vitro Fertilization and Embryo Transfer

Pregnancy Outcomes of Patients with Polycystic Ovary Syndrome Undergoing in Vitro Fertilization and Embryo Transfer

Clinical Outcomes of <i>In Vitro</i> Maturation After Oocyte Retrieval With Gynecological Surgery for Refractory Polycystic Ovary Syndrome: A Retrospective Cohort Study

Clinical Outcomes of In Vitro Maturation After Oocyte Retrieval With Gynecological Surgery for Refractory Polycystic Ovary Syndrome: A Retrospective Cohort Study

Comparison of two in vitro gonadotrophin priming protocols in maturation treatment of patients with polycystic ovary syndrome

Outcomes of subsequent IVF cycles among women with PCOS after the first unstimulated IVM treatment: a single-center matched retrospective case-control study

[Outcome of in Vitro Fertilization-Embryo Transfer in Treatment of Polycystic Ovarian Syndrome].

Effects of Polycystic Ovary Syndrome (PCOS) on the Outcome of the Patients Receiving in Vitro Fertilization and Embryo Transfer(ivf-Et)treatment

A Meta-Analysis of Oocyte Quality and Clinical Outcome of Intracytoplasmic Sperm Injection Cycles in Patients with Polycystic Ovary Syndrome

Live Birth after in Vitro Maturation Versus Standard in Vitro Fertilisation for Women with Polycystic Ovary Syndrome: Protocol for a Non-Inferiority Randomised Clinical Trial

Pregnancy Outcomes of Women With Polycystic Ovary Syndrome for the First In Vitro Fertilization Treatment: A Retrospective Cohort Study With 7678 Patients

Comparison of Endocrine Profile Andin VitroFertilization Outcome in Patients with PCOS, Ovulatory PCO, or Normal Ovaries

Development of frozen-thawed embryos derived from immature human oocytes following in-vitro maturation and fertilization in women with PCOS

Pregnancy outcome and its causes in patients with polycystic ovary syndrome after in vitro fertilization and embryo transfer

Outcomes of the Next In Vitro Fertilization Cycle in Women with Polycystic Ovary Syndrome after a Failed In Vitro Maturation Attempt

Association Between Menstrual Patterns and Adverse Pregnancy Outcomes in Patients With Polycystic Ovary Syndrome

Retrospective comparison of IVF treatment in women with PCOS, PCO or normal ovaries